TrialJectory
AI-powered platform connecting cancer patients to advanced treatments and clinical trials.
About
TrialJectory is an AI-powered decision support platform that democratizes access to advanced cancer treatments. It empowers patients to own their cancer journey by providing instant, personalized lists of cutting-edge treatments matched to their exact diagnosis, free of pharmaceutical bias. The company serves cancer patients by connecting them with treatment options and offers dedicated support from a team of medical professionals. Teams look it up for Healthcare, Clinical Trials, Cancer.
Frequently asked
What does TrialJectory do?
TrialJectory is a Healthcare company that offers Software. Teams look it up for Clinical Trials, Cancer, HealthTech. It is based in New York, United States and was founded in 2017. Public records show about 17 people and $40M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has TrialJectory raised?
TrialJectory has raised a total of $40M in funding. The most recent round on record is Series A.
Where is TrialJectory headquartered?
TrialJectory is headquartered in New York, United States.
When was TrialJectory founded?
TrialJectory was founded in 2017.
What industry does TrialJectory operate in?
TrialJectory operates in Healthcare, Clinical Trials, Cancer, HealthTech, MedTech.
How many employees does TrialJectory have?
TrialJectory has approximately 17 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.